期刊文献+

5—氮胞苷诱导对骨髓间充质干细胞凋亡影响的实验研究 被引量:1

Experiment study of 5—azacytidine on apoptosis of bone mesenchymal stem cell
下载PDF
导出
摘要 目的:研究5-氮胞苷(5-azacytidine,5-aza)对体外培养的兔骨髓间充质干细胞(mensenchymal stem cell, MSC)凋亡的影响。方法:体外分离培养兔 MSC,用不同浓度5-aza 诱导不同时间,观察 MSC 凋亡情况。结果:正常培养兔 MSC 有轻度细胞凋亡;5-aza 诱导浓度达15μmol/L 时凋亡率明显增加(P<0.01),当浓度达10μmol/L, 诱导时间延长则细胞凋亡率明显增加(P<0.05),超过15μmol/L 时出现成片细胞死亡。结论:5-aza 诱导对体外培养兔骨髓间质干细胞有诱导细胞凋亡作用,其作用程度与诱导时间及浓度有关。 Objective: To assess the effects of 5-azacytldine (aza) on the apoptosis of rabbit bone mesenchymal stem cell (MSC). Methods : Rabbit bone marrow cell was taken out and incubated with different concentration and time of 5-aza. The apoptosis of rabbit MSC was observed. Results: The apoptosis of normal MSC was light. After treated with 5-aza, the apoptosis of MSC gradually increased, but when the 5-aza concentration incubated MSC≤10μmol/L, the apoptosis of MSC increased was no significant. When the 5-aza content to achieved 15μmol/L the apoptosis of MSC significantly increased (P〈0. 01); the 5-aza concentration more than 15μmol/L massive died MSC was showed. When 5-aza concentration〈 10μmol/L, although the incubative time increased but the apoptosis of MSC increase was no significant; when 5-aza concentration to achieved 10 μmol/L the apoptosis of MSC significantly increased (P〈0. 05). Conclusion:The apoptosis of the rabbit MSC incubated by 5-aza is determined by 5-aza concentration and incubated time.
出处 《心血管康复医学杂志》 CAS 2006年第2期111-113,121,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 5-氮胞苷 间质干细胞 细胞凋亡 5-azaeytidine Mensenchymal stem cell Apoptosis
  • 相关文献

参考文献10

  • 1Minguell J J, Conger P. Erices A. Biology and clinical utilization of mesenchymal progenitor cells [J]. Braz J Med Biol Res. 2000. 33 (8); 881-887.
  • 2方志成,王玮,黄从新,王为民,何朝荣.骨髓间(充)质干细胞体外定向诱导心肌样细胞超微结构特征研究[J].心血管康复医学杂志,2005,14(6):522-524. 被引量:2
  • 3Charles E, Mark H, Hans R, et al. Haematopietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts [J]. Nature, 2004 (6893), 428:664-668.
  • 4Leora B, Amy J, Julie L, et al, Haematopietic stem cells adopt mature haematopoietic fates in ischaemic myocardium [J]. Nature, 2004, 428 (6893): 668-673.
  • 5Makino S, Fukuda K, Miyoshi S, et al, Cardiomyocytes can be generated from marrow stromal cells invitro [J]. J clin Invest, 1999, 103 (5):697-705.
  • 6王劲.DNA甲基化[J].国外医学(临床生物化学与检验学分册),2002,23(4):206-207. 被引量:1
  • 7Kitagawa Y, Kyo S, Takakura M, et al. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT [J]. Clin Cancer Res, 2000. 6 (7): 2868-2875.
  • 8Wei GZ, Theresa H, Yang K, et al. 5-Aza-2'-deoxycytidine Activates the p53/p21^waft/cipl Pathway to inhibit cell proliferation [J]. J Biol Chem, 2004, 279 (15): 15161-15166.
  • 9乔淑凯,徐世荣,郭晓楠.5-氮杂脱氧胞苷对白血病细胞生长作用及相关基因表达的影响[J].中华血液学杂志,2004,25(8):486-490. 被引量:11
  • 10Lin TXi, Chao C, Saoto S, et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression [J]. Nat Cell Biol, 2005, 7 (2): 165-171.

二级参考文献29

  • 1Charles E,Mark H,Hans R,et al.Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts[J].Nature,2004,428:664-668.
  • 2Leora B,Amy J,Julie L,et al.Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium[J].Nature,2004,428:668-673.
  • 3Minguell JJ,Conger P,Erices A.Biology and clinical utilizationof mesenchymal progenitor cells[J].Braz J Med Biol Res,2000,33:881-887.
  • 4Konieczy SF,Emerson CP.5-azacytidine induction of stable mesodermal stem cell lineage from 10 T 1/2 cells:evidence of regulatory genes controlling determination[J].Cell,1984,38:791.
  • 5Makino S,Fukuda K,Miyoshi S,et al.Cardiomyocytes can be generated from marrow stromal cells in vitro[J].J Clin Invest.1999,103:697-705.
  • 6Nag AC,Schultz DE,Lee ML.et al.Expression of atrial natriuretic peptide in cultureed adult cardiac ventricular muscle cells as studied by immnofluorescence microscopy[J].Cell Mol Bio,1995,41(6):813-819.
  • 7Fukuda K.Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes[J].Bone Marrow transplation,2003,32:S25-S27.
  • 8Guan K,Furst DO,Wobus AM,et al.Modulation of saycomere organization during embryonic stem cell-derived cardiomyocyte differentiation[J].Eur J Cell Biol,1999,78 (11):813-823.
  • 9Mizuno S, Chijiwa T, Okamura T, et al. Expression of DNA methyltransferases DNMT1,3A, and 3B in normal hematopoiesisand in acute and chronic myelogenous leukemia. Blood,2001,97:1172-1179.
  • 10Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG island.Proc Natl Acad Sci U S A, 1996, 93: 9821-9826 .

共引文献11

同被引文献12

  • 1Richardson P, Mckenna W, Bristow M, et al. Report of the 1995 world health organization/in--ternational society and federation of cardiology task force on the definition and classification of car diomyopathies[J]. Circulation, 1996,93(5) :841.
  • 2Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies.-an American Heart Association Scientific Statement from the Council on Clinical Car diology, Heart Failure and Transplantation Committee: Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups: and Council on Epidemiology and Prevention [J].Circulation, 2006, 113(14) :1807.
  • 3Slack JM,Tosh D. Transdifferentiation and metaplasia switching cell types[J]. Curr Opin Genet Dev,2001,11(5) ;581.
  • 4Bianco P,Riminucei M,Gronthos S, et al. Bone marrow stromal stem cells: Nature, biology, and potential applications [J]. Stem cells, 2001,19 :180.
  • 5Luk A, Ahn E, Soor GS, Butany J. Dilated cardiomyopathy: a re- view[J]. J Clin Pathol,2009,62(3) :219.
  • 6Noriteshi Nagaya,Kenji Kngawa, el al. Transplantation of Mes- enchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy[J]. Circulation,2005,112(8) : 1128.
  • 7Granero-Molto F,Weis JA, Longobardi L, et al. Role of mesen chymal stem cells in regenerative medicine: application to bone and cartilage repair[J]. Expert Opin Biol Ther, 2008,8(3) : 255.
  • 8In't Anker PS,Scherion SA,Kleijburg-van der Keur C,et al. Am- niotic fluid as a novel source of mesenehymal stem cells for thera peutic transplantation[J]. Blood,2003,102(4) : 1548.
  • 9Iwase T,Nagaya N,Fujii T,et al. Comparison of angiogenic po- teney between mesenchymal stem ceils and mononuclear cells in a rat model of hindlimb ischemia[J]. Cardiovasc Res, 2005,66 (3) :543.
  • 10Moscoso I, Centeno A, Lopez E, et al. Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem ceils in- to cardiomyocytes for cell transplantation[J]. Transplant Proc, 2005 ;37(1) :481.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部